India Partners with BRICS Group to Setup Network of Genomic Surveillance and Study the Overlap of SARS-CoV-2 with tuberculosis

India Partners with BRICS Group to Setup Network of Genomic Surveillance and Study the Overlap of SARS-CoV-2 with tuberculosis

• The Department of Biotechnology, Ministry of Science and Technology, Government of India has collaborated with BRICS countries to implement SARS-CoV-2 NGS-BRICS consortium and multi centric programme for  studying the impact of severe COVID-19 conditions on TB patients.
• SARS-CoV-2 NGS-BRICS consortium: is an interdisciplinary collaboration to advance COVID-19 health-relevant knowledge and to contribute to improvements in health outcomes. 
• Multi centric programme: is an interdisciplinary team of researchers from India, Brazil and South Africa, to investigate the impact of severe COVID-19 on transient peripheral immunosuppression and lung hyperinflammation conditions in TB patients for epidemiology and comorbidity. 
• The collaborative study would provide valuable co-morbidity data pertaining to pulmonary TB patients with or without COVID-19 co-infection, for better disease management.

Source: PIB

Points to Remember: 

1. India has partnered with which inter-governmental group to study the impact of severe COVID-19 conditions on TB patients? BRICS